FDA regulatory due diligence involves reviewing the key regulatory requirements before entering the United States market. A structured review helps identify compliance gaps, improve regulatory readiness and support successful regulatory submission and...

MoCRA has introduced several requirements for Cosmetic companies selling products in the United States. These include facility registration, product listing, safety documentation, recordkeeping, serious adverse event reporting, labelling, and post-market responsibilities. Meeting...

Short Description The FDA Q-Submission Program is an important regulatory pathway that helps Medical Device sponsors reduce potential risks before submitting a formal application. By obtaining early FDA feedback, sponsors can clarify...

Short Description The FDA Q-Submission Program is a voluntary process that allows Medical Device developers to communicate with the United States Food and Drug Administration before submitting a formal regulatory application. It...

A marketing authorization holder (MAH) plays a critical role in ensuring that medicinal products marketed in the European Union (EU) continue to meet Regulatory standards for quality, safety, and efficacy throughout their...

Technical documentation is a fundamental requirement under the European Union Medical Device Regulation (EU MDR 2017/745) and In Vitro Diagnostic Medical Device Regulation (EU IVDR 2017/746). It provides evidence that a Medical...

CE Marking is a mandatory regulatory requirement for Medical Devices marketed in the European Union (EU) and European Economic Area (EEA). It confirms that a device meets necessary safety standards, health, and...

MHRA is the UK’s official regulatory body that oversees medicines, vaccines, and Medical Devices to ensure they meet strict standards of safety, quality, and effectiveness. It evaluates products before approval, monitors them...